Head-To-Head Analysis: Bio-Rad Laboratories (NYSE:BIO.B) Versus Cue Health (NASDAQ:HLTH)
Head-To-Head Analysis: Bio-Rad Laboratories (NYSE:BIO.B) Versus Cue Health (NASDAQ:HLTH)
Bio-Rad Laboratories (NYSE:BIO.B – Get Rating) and Cue Health (NASDAQ:HLTH – Get Rating) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, earnings, analyst recommendations, valuation and risk.
Bio-Rad实验室(纽约证券交易所代码：BIO.B-GET评级)和Cue Health(纳斯达克：HLTH-GET评级)都是医疗公司，但哪一家是更好的投资？我们将根据这两家公司的盈利能力、股息、机构所有权、收益、分析师建议、估值和风险的强弱进行比较。
Insider & Institutional Ownership
内部人与机构所有权
0.0% of Bio-Rad Laboratories shares are held by institutional investors. Comparatively, 37.9% of Cue Health shares are held by institutional investors. 28.4% of Bio-Rad Laboratories shares are held by insiders. Comparatively, 29.4% of Cue Health shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Bio-Rad实验室0.0%的股份由机构投资者持有。相比之下，机构投资者持有Cue Health 37.9%的股份。Bio-Rad实验室28.4%的股份由内部人士持有。相比之下，Cue Health 29.4%的股份由内部人士持有。强大的机构持股表明，对冲基金、捐赠基金和大型基金经理相信，从长期来看，一只股票的表现将好于大盘。
Profitability
盈利能力
This table compares Bio-Rad Laboratories and Cue Health's net margins, return on equity and return on assets.
此表比较了Bio-Rad实验室和Cue Health的净利润率、股本回报率和资产回报率。
| Net Margins | Return on Equity | Return on Assets | |
| Bio-Rad Laboratories | -67.66% | 3.82% | 2.84% |
| Cue Health | -6.24% | 5.50% | 3.99% |
| 净利润率 | 股本回报率 | 资产回报率 | |
| Bio-Rad实验室 | -67.66% | 3.82% | 2.84% |
| 球杆健康 | -6.24% | 5.50% | 3.99% |
Earnings and Valuation
收益和估值
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Bio-Rad Laboratories | $2.92 billion | 4.25 | $4.25 billion | ($66.32) | -6.31 |
| Cue Health | $618.11 million | 0.70 | $86.42 million | ($0.30) | -9.77 |
| 总收入 | 价格/销售额比 | 净收入 | 每股收益 | 市盈率 | |
| Bio-Rad实验室 | 29.2亿美元 | 4.25 | 42.5亿美元 | ($66.32) | -6.31 |
| 球杆健康 | 6.1811亿美元 | 0.70 | 8642万美元 | ($0.30) | -9.77 |
Bio-Rad Laboratories has higher revenue and earnings than Cue Health. Cue Health is trading at a lower price-to-earnings ratio than Bio-Rad Laboratories, indicating that it is currently the more affordable of the two stocks.
Bio-Rad实验室的收入和收益比Cue Health更高。Cue Health的市盈率低于Bio-Rad实验室，这表明它目前是两只股票中更负担得起的一只。
Analyst Recommendations
分析师建议
This is a breakdown of current ratings and price targets for Bio-Rad Laboratories and Cue Health, as reported by MarketBeat.
这是MarketBeat报道的Bio-Rad实验室和Cue Health的当前评级和目标价的细目。
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Bio-Rad Laboratories | 0 | 0 | 0 | 0 | N/A |
| Cue Health | 0 | 1 | 0 | 0 | 2.00 |
| 销售评级 | 保持评级 | 购买评级 | 强劲的买入评级 | 评级分数 | |
| Bio-Rad实验室 | 0 | 0 | 0 | 0 | 不适用 |
| 球杆健康 | 0 | 1 | 0 | 0 | 2.00 |
Cue Health has a consensus price target of $8.67, suggesting a potential upside of 195.79%. Given Cue Health's higher possible upside, analysts plainly believe Cue Health is more favorable than Bio-Rad Laboratories.
Cue Health的共识目标价为8.67美元，这意味着潜在的上涨幅度为195.79。考虑到Cue Health更有可能的上行空间，分析师们显然认为Cue Health比Bio-Rad实验室更有利。
Summary
摘要
Cue Health beats Bio-Rad Laboratories on 7 of the 11 factors compared between the two stocks.
Cue Health在两只股票之间进行比较的11个因素中，有7个超过了Bio-Rad实验室。
About Bio-Rad Laboratories
关于Bio-Rad实验室
(Get Rating)
(获取评级)
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. In addition, the company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
Bio-Rad实验室公司在美国、欧洲、亚洲、加拿大和拉丁美洲制造和分销生命科学研究和临床诊断产品。该公司通过生命科学和临床诊断部门开展业务。生命科学部门开发、制造和营销一系列试剂、仪器和实验室仪器，用于研究技术、生物制药生产过程和食品检测制度。它专注于蛋白质组学、基因组学、生物制药生产、细胞生物学和食品安全等生命科学市场的部分领域。这一细分市场为大学和医学院、工业研究组织、政府机构、制药商、生物技术研究人员、食品生产商和食品检测实验室提供服务。临床诊断部门为诊断市场中的临床实验室设计、制造、销售和支持测试系统、信息学系统、测试工具包和专门的质量控制。这一细分市场提供试剂、仪器和软件，以满足体外诊断测试市场中的特定利基市场。它向参考实验室、医院实验室、国家新生儿筛查机构、医生办公室实验室和输血实验室销售产品。此外，该公司还提供分离复杂化学和生物材料以及识别、分析和提纯成分的产品和系统。该公司通过其直销队伍，以及通过分销商、代理商、经纪人和转售商提供产品。Bio-Rad实验室公司成立于1952年，总部设在加利福尼亚州大力神。
About Cue Health
关于Cue Health
(Get Rating)
(获取评级)
Cue Health Inc., a healthcare technology company, designs and develops diagnostic platform for diagnostic tests for individuals, enterprises, healthcare providers and payors, and public health agencies. The company offers Cue Integrated Care platform comprising hardware and software components, such as Cue Health Monitoring System consisting of Cue Reader, a portable and reusable reader, Cue Cartridge, a single-use test cartridge, and Cue Wand, a sample collection wand; Cue Data and Innovation Layer, a solution with cloud-based data and analytics capability; Cue Virtual Care Delivery Apps, which include Cue Health App and Cue Enterprise Dashboard; and Cue Ecosystem Integrations and Apps, a solution that allows integrations with third-party applications and sensors. It also provides COVID-19 testing kits for the Cue Health Monitoring System The company was formerly known as Cue Inc and changed its name to Cue Health Inc. in December 2017. Cue Health Inc. was incorporated in 2010 and is headquartered in San Diego, California.
CUE Health Inc.是一家医疗保健技术公司，为个人、企业、医疗保健提供者和付款人以及公共卫生机构设计和开发诊断测试诊断平台。该公司提供由硬件和软件组件组成的Cue集成护理平台，例如由Cue Reader(便携式可重复使用的读取器)、Cue Cartridge(一次性测试墨盒)和Cue Wand(样本采集棒)组成的Cue Health Monitor System；Cue Data and Innovation Layer，具有基于云的数据和分析能力的解决方案；Cue虚拟护理交付应用，包括Cue Health App和Cue Enterprise Dashboard；以及Cue Ecoessis集成和应用，允许与第三方应用和传感器集成。它还为CUE健康监测系统提供新冠肺炎检测试剂盒，该公司前身为CUE Inc.，并于2017年12月更名为Cue Health Inc.。CUE Health Inc.成立于2010年，总部设在加利福尼亚州圣地亚哥。
Receive News & Ratings for Bio-Rad Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bio-Rad Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
每天收到Bio-Rad实验室的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收对Bio-Rad实验室和相关公司的最新新闻和分析师评级的每日简要摘要。